Effect of Thyroxine Replacement on Creatinine, Insulin-Like Growth Factor 1, Acid-Labile Subunit, and Vascular Endothelial Growth Factor
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (1) , 228-231
- https://doi.org/10.1373/clinchem.2003.021022
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effects of vascular endothelial growth factor (EGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidneyNephrology Dialysis Transplantation, 1998
- Flow-Mediated, Endothelium-Dependent Vasodilatation Is Impaired in Subjects with Hypothyroidism, Borderline Hypothyroidism, and High-Normal Serum Thyrotropin (TSH) ValuesThyroid®, 1997
- Changes in renal function in primary hypothyroidismAmerican Journal of Kidney Diseases, 1996
- Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cellsKidney International, 1994
- Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat.Journal of Clinical Investigation, 1991
- Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor IKidney International, 1991
- Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrationsThe Journal of Pediatrics, 1989
- EFFECT OF THYROXINE REPLACEMENT THERAPY ON PLASMA INSULIN‐LIKE GROWTH FACTOR 1 LEVELS AND GROWTH HORMONE RESPONSES TO GROWTH HORMONE RELEASING FACTOR IN HYPOTHYROID PATIENTSClinical Endocrinology, 1987
- Hypothyroidism as a cause of hypertension.Hypertension, 1983
- Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.Journal of Clinical Investigation, 1981